EBV PCR detects and quantifies the virus directly, which is especially important in transplant recipients and other immunocompromised patients where reactivation can cause post-transplant lymphoproliferative disease (PTLD) or other EBV-associated complications. Quantitative measurement allows tracking of viral burden over time.
This test is used in post-transplant monitoring, evaluation of suspected PTLD, assessment of EBV-associated cancers (such as nasopharyngeal carcinoma or Burkitt lymphoma), and certain cases of chronic active EBV. Sample type is whole blood, plasma, or tissue.
We are CLIA certified, the highest level of Medical industry compliance and standards.
Book an appointment